Quest Diagnostics (NY:DGX)

232.28 -1.05 (-0.45%)

Delayed Quote Updated: 10:23 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Should You Buy Guardant Health Before Feb. 19? ↗

January 30, 2026

This genomics stock appears to be at an inflection point.

Via The Motley Fool

Topics Earnings

January 18, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps...

Via StockStory

Quest Diagnostics Inc. (NYSE:DGX): A Prime Pick for Steady, Growing Dividends ↗

January 15, 2026

Via Chartmill

3 Mid-Cap Stocks We Find Risky

January 14, 2026

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

3 Reasons to Sell DGX and 1 Stock to Buy Instead

January 13, 2026

Quest trades at $179.96 and has moved in lockstep with the market. Its shares have returned 6.9% over the last six months while the S&P 500 has gained 11.3%.

Via StockStory

Topics Stocks

GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth

January 13, 2026

In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an...

Via MarketMinute

Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks

January 01, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q3, starting...

Via StockStory

Quest Diagnostics Inc. (NYSE:DGX) Stands Out as a Dependable Dividend Stock ↗

December 16, 2025

Quest Diagnostics (DGX) offers a reliable dividend with a strong yield, backed by consistent growth, solid profitability, and a sustainable payout ratio for income investors.

Via Chartmill

1 S&P 500 Stock to Target This Week and 2 We Brush Off

December 11, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Quest (DGX) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Quest (DGX) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Quest Diagnostics Inc (NYSE:DGX) Presents a Strong Case for Dividend Investors ↗

November 22, 2025

Quest Diagnostics (DGX) offers a strong dividend profile with a 1.71% yield, steady growth, and a sustainable payout, backed by solid profitability and financial health.

Via Chartmill

Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Via StockStory

Topics Economy

Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing ↗

November 14, 2025

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

Via Benzinga

Quest Diagnostics Solidifies Shareholder Value with $0.80 Quarterly Dividend

November 11, 2025

Securing Shareholder Returns in a Dynamic Healthcare Landscape Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, has declared a quarterly cash dividend of $0.80 per...

Via MarketMinute

Quest Diagnostics (NYSE: DGX) Bolsters Shareholder Confidence with Latest Dividend Declaration

November 11, 2025

Secaucus, NJ – November 11, 2025 – Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, has declared a quarterly cash dividend of $0.80 per share, reaffirming its...

Via MarketMinute

Economic Crossroads: How Key Indicators Are Steering the Stock Market Through Moderation and Policy Shifts

November 05, 2025

The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers'...

Via MarketMinute

Topics Artificial Intelligence Economy Immigration

3 Low-Volatility Stocks We Think Twice About

November 02, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

3 Healthcare Stocks We Steer Clear Of

October 31, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This...

Via StockStory

Topics Stocks

Why Guardant Health Stock Surged Today ↗

October 30, 2025

The healthcare company's innovative cancer tests are helping to save lives.

Via The Motley Fool

Price Over Earnings Overview: Quest Diagnostics ↗

October 24, 2025

Via Benzinga

1 Profitable Stock to Target This Week and 2 Facing Challenges

October 24, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Quest Diagnostics Inc (NYSE:DGX): A Dividend Stock Analysis for Income Investors ↗

October 23, 2025

Quest Diagnostics (DGX) offers a strong dividend yield, steady growth, and sound financials for reliable income. Its manageable payout ratio ensures lasting payments.

Via Chartmill

Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings ↗

October 22, 2025

Via Benzinga

Top S&P500 movers in Tuesday's session ↗

October 21, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

October 21, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below.

Via Chartmill

Quest Diagnostics Reports Q3 Earnings, Shares Slide ↗

October 21, 2025

Shares of Quest Diagnostics (NASDAQ: DGX) are falling Tuesday after the medical laboratories company shared mixed earnings results.

Via Benzinga

Stay informed with the top movers within the S&P500 index on Tuesday. ↗

October 21, 2025

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Which S&P500 stocks are gapping on Tuesday? ↗

October 21, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session.

Via Chartmill

Gold Sinks 5% On Worst Day In 5 Years, Dow Jones Hits Record Highs: What's Moving Markets Tuesday? ↗

October 21, 2025

Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, while optimism across earnings kept industrial stocks powering higher and pushed...

Via Benzinga

Topics Stocks

Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗

October 21, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.